Becker's Healthcare February 6, 2024
Insurers are reporting rising costs in the Medicare Advantage business but differ in their predictions of how these trends will affect their business in 2024.
On a Feb. 6 call, Centene executives reassured investors the company priced for rising costs in its 2024 guidance.
“While Medicare has been a hot topic for the industry of late, we are pleased that the annual enrollment period played out largely as expected for Centene, and our 2024 financial projections for Medicare remain unchanged from investor day,” Centene CEO Sarah London said.
Centene was the sixth largest Medicare Advantage insurer in 2023, according to KFF. Humana, the second-largest insurer, cut its 2024 and 2025 earnings expectations on the assumption that Medicare...
Today's Sponsors
Today's Sponsor